Question 1 · Easy
Tacrolimus prevents transplant rejection by:
- AInhibiting xanthine oxidase
- BInhibiting calcineurin, reducing IL-2 production
- CInhibiting inosine monophosphate dehydrogenase in lymphocytes
- DBlocking the CD20 antigen
Show answerHide answer
Answer: B · Inhibiting calcineurin, reducing IL-2 production
Tacrolimus binds FKBP-12, and the complex inhibits calcineurin, which prevents NFAT dephosphorylation and IL-2 transcription, so T cell activation is reduced. Ciclosporin acts through the same pathway via cyclophilin. Trough levels are monitored because of its narrow therapeutic index.
- A: Xanthine oxidase inhibition is the action of allopurinol.
- C: IMPDH inhibition is the action of mycophenolate.
- D: CD20 is the target of rituximab.
Remember this
Calcineurin inhibitors (tacrolimus, ciclosporin) block IL-2 synthesis; monitor trough levels.